‘I am just a shadow of who I used to be’—Exploring existential loss of identity among people living with chronic conditions of Long COVID
Very interesting new article on Long COVID published by Sociology of Health and Illness (Wiley). ‘I am just a shadow…
WHO’s Statement – 36 million people across the European Region may have developed long COVID over the first 3 years of the pandemic
Statement by Dr Hans Henri P. Kluge, WHO Regional Director for Europe to the press on COVID-19, extreme…
Webinar – LONG COVID: WHAT NEEDS TO HAPPEN NEXT? (5 & 6 July 2023)
NIHR Clinical Research Network in collaboration with Long Covid Support & Long Covid Scotland will hold a two-day Long COVID Webinar: Long COVID: What needs…
Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial
New relevant publication on The Lancet! “An inhaled Covid vaccine booster was more than 5-fold effective for inducing…
Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies
Interesting literature review published by The Lancet with an analysis of studies that looked for the persistence of SARS-CoV-2 RNA…
Long COVID: The impact on language and cognition
The new article by Professor Louise Cummings (Department of English and Communication, The Hong Kong Polytechnic University) examines in…
Fighting Post-COVID and ME/CFS – development of curative therapies
Currently, there are no curative therapies for Post-COVID or ME/CFS. A German study led by Charité – Universitätsmedizin Berlin proposes the evaluation…
2nd Long COVID Press Release
On the occasion of its first year of implementation, the Long COVID project just launched a new Press…